使用JAK抑制剂成功治疗度普利尤单抗诱导的银屑病性皮炎/关节炎和特应性皮炎：一例病例报告及文献综述
Successful treatment of the dupilumab-induced psoriatic dermatitis/arthritis and atopic dermatitis with a JAK inhibitor: A case report and literature review.
作者信息
Tsunoda Misuzu, Adachi Takeya, Nakajima Yuuri, Yatomi Yoshihiro, Shimizu Tomoko, Nakasute Katsuki
机构信息
Department of Dermatology, National Hospital Organization Saitama Hospital, Saitama, Japan.
Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
出版信息
J Allergy Clin Immunol Glob. 2024 Aug 5;3(4):100323. doi: 10.1016/j.jacig.2024.100323. eCollection 2024 Nov.
Abstract
Dupilumab-induced psoriatic dermatitis and arthritis in a patient with atopic dermatitis were effectively managed with upadacitinib, highlighting the use of Janus kinase inhibitors as a possible treatment for biologic therapy side effects.
摘要
对于一名患有特应性皮炎的患者，度普利尤单抗诱发的银屑病性皮炎和关节炎通过乌帕替尼得到了有效控制，这凸显了使用 Janus 激酶抑制剂作为生物治疗副作用的一种可能治疗方法。
Zotero 插件